216 related articles for article (PubMed ID: 32014494)
1. New OFSEP recommendations for MRI assessment of multiple sclerosis patients: Special consideration for gadolinium deposition and frequent acquisitions.
Brisset JC; Kremer S; Hannoun S; Bonneville F; Durand-Dubief F; Tourdias T; Barillot C; Guttmann C; Vukusic S; Dousset V; Cotton F;
J Neuroradiol; 2020 Jun; 47(4):250-258. PubMed ID: 32014494
[TBL] [Abstract][Full Text] [Related]
2. [Use of Gadolinium in Follow-Up MRI of Multiple Sclerosis Patients: Current Recommendations].
Cruz A; Pereira D; Batista S
Acta Med Port; 2024 Jan; 37(1):53-63. PubMed ID: 38183232
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Unenhanced and Gadolinium-Enhanced Imaging in Multiple Sclerosis: Is Contrast Needed for Routine Follow-Up MRI?
Sadigh G; Saindane AM; Waldman AD; Lava NS; Hu R
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1476-1480. PubMed ID: 31439627
[TBL] [Abstract][Full Text] [Related]
4. Update on brain MRI for the diagnosis and follow-up of MS patients.
Brisset JC; Vukusic S; Cotton F;
Presse Med; 2021 Jun; 50(2):104067. PubMed ID: 33989722
[TBL] [Abstract][Full Text] [Related]
5. The role of contrast-enhanced and non-contrast-enhanced MRI in the follow-up of multiple sclerosis.
Zarei F; Ghaedian M; Ghaedian T
Acta Radiol; 2021 Jul; 62(7):916-921. PubMed ID: 32762243
[TBL] [Abstract][Full Text] [Related]
6. The contemporary role of MRI in the monitoring and management of people with multiple sclerosis in the UK.
Fernandes L; Allen CM; Williams T; Tallantyre E; Evangelou N; Chataway J; Ford HL;
Mult Scler Relat Disord; 2021 Oct; 55():103190. PubMed ID: 34365316
[TBL] [Abstract][Full Text] [Related]
7. The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study.
Dallera G; Affinito G; Caliendo D; Petracca M; Carotenuto A; Triassi M; Brescia Morra V; Palladino R; Moccia M
Mult Scler Relat Disord; 2023 Jan; 69():104423. PubMed ID: 36436395
[TBL] [Abstract][Full Text] [Related]
8. The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
Tsantes E; Curti E; Ganazzoli C; Puci F; Bazzurri V; Fiore A; Crisi G; Granella F
J Neurol; 2020 Sep; 267(9):2642-2647. PubMed ID: 32399696
[TBL] [Abstract][Full Text] [Related]
9. Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
Harrison DM; Allette YM; Zeng Y; Cohen A; Dahal S; Choi S; Zhuo J; Hua J
PLoS One; 2024; 19(5):e0300298. PubMed ID: 38809920
[TBL] [Abstract][Full Text] [Related]
10. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
Paolillo A; Piattella MC; Pantano P; Di Legge S; Caramia F; Russo P; Lenzi GL; Pozzilli C
J Neurol; 2004 Apr; 251(4):432-9. PubMed ID: 15083288
[TBL] [Abstract][Full Text] [Related]
11. Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis.
Traboulsee A; Simon JH; Stone L; Fisher E; Jones DE; Malhotra A; Newsome SD; Oh J; Reich DS; Richert N; Rammohan K; Khan O; Radue EW; Ford C; Halper J; Li D
AJNR Am J Neuroradiol; 2016 Mar; 37(3):394-401. PubMed ID: 26564433
[TBL] [Abstract][Full Text] [Related]
12. Structured Reporting in Multiple Sclerosis - Consensus-Based Reporting Templates for Magnetic Resonance Imaging of the Brain and Spinal Cord.
Riederer I; Mühlau M; Wiestler B; Bender B; Hempel JM; Kowarik M; Huber T; Zimmer C; Andrisan T; Patzig M; Zimmermann H; Havla J; Berlis A; Behrens L; Beer M; Dietrich J; Sollmann N; Kirschke JS
Rofo; 2023 Feb; 195(2):135-138. PubMed ID: 35913055
[TBL] [Abstract][Full Text] [Related]
13. Altered signal intensity of active enhancing inflammatory lesions using post-contrast double inversion recovery MR sequence.
Hodel J; Badr S; Outteryck O; Lebert P; Chechin D; Benadjaoud MA; Pruvo JP; Vermersch P; Leclerc X
Eur Radiol; 2017 Feb; 27(2):637-641. PubMed ID: 27229340
[TBL] [Abstract][Full Text] [Related]
14. OFSEP, a nationwide cohort of people with multiple sclerosis: Consensus minimal MRI protocol.
Cotton F; Kremer S; Hannoun S; Vukusic S; Dousset V;
J Neuroradiol; 2015 Jun; 42(3):133-40. PubMed ID: 25660217
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
16. The evaluation of MRI diffusion values of active demyelinating lesions in multiple sclerosis.
Abdoli M; Chakraborty S; MacLean HJ; Freedman MS
Mult Scler Relat Disord; 2016 Nov; 10():97-102. PubMed ID: 27919508
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of Unenhanced MRI in the Detection of New Brain Lesions in Multiple Sclerosis.
Eichinger P; Schön S; Pongratz V; Wiestler H; Zhang H; Bussas M; Hoshi MM; Kirschke J; Berthele A; Zimmer C; Hemmer B; Mühlau M; Wiestler B
Radiology; 2019 May; 291(2):429-435. PubMed ID: 30860448
[TBL] [Abstract][Full Text] [Related]
18. Impact of post-contrast MRI in the definition of active multiple sclerosis.
Gentili L; Capuano R; Gaetani L; Fiacca A; Bisecco A; d'Ambrosio A; Mancini A; Guercini G; Tedeschi G; Parnetti L; Gallo A; Di Filippo M
J Neurol Sci; 2022 Sep; 440():120338. PubMed ID: 35853292
[TBL] [Abstract][Full Text] [Related]
19. Comparison between gadolinium-enhanced 2D T1-weighted gradient-echo and spin-echo sequences in the detection of active multiple sclerosis lesions on 3.0T MRI.
Aymerich FX; Auger C; Alcaide-Leon P; Pareto D; Huerga E; Corral JF; Mitjana R; Sastre-Garriga J; Montalban X; Rovira A
Eur Radiol; 2017 Apr; 27(4):1361-1368. PubMed ID: 27456965
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal Enhancement on 3D-FLAIR MRI in Multiple Sclerosis: Systematic Observations in Clinical Practice.
Titelbaum DS; Engisch R; Schwartz ED; Napoli SQ; Sloane JA; Samaan S; Katz JD; Lathi ES
J Neuroimaging; 2020 Nov; 30(6):917-929. PubMed ID: 32830899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
